Our Visionary Mission
Pioneering a future free from HCMV through transformative immunotherapy.
Pioneering a future free from HCMV through transformative immunotherapy.
Our Dense Bodies redefine immunotherapy, delivering unmatched antigen diversity to combat HCMV with precision and safety.
We aim to protect millions worldwide, from transplant patients to newborns, with solutions that set new standards in biotech.
With a foundation of rigorous research and global patents, we drive innovation that transforms lives.
HSCT patients safeguarded annually by 2033, with millions of newborns protected thereafter
Years of pioneering research
Partnerships for impact
Join Dense Immune to lead the charge in HCMV immunotherapy and transform global health.
Partner with Us